Frank Barry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Frank Barry has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Josephine Mary Murphy
Regenerative Medicine Institute, National University of Ireland Galway, Galway, Ireland
7 shared publications Raymond E. Boynton
Osiris Therapeutics Inc
3 shared publications- Joseph Zaia
Center for Biomedical Mass Spectrometry, Boston University Chobanian & Avedisian School of Medicine, 670 Albany Street, Boston, Massachusetts 02118, United States
2 shared publications Mary Murphy
National Univ. of Ireland, Galway (Ireland)
2 shared publicationsAndrew Feldman
University Place Orthopaedics, New York, New York
1 shared publicationBarry M. McGrath
Regenerative Medicine Institute, NUI Galway, Galway, Ireland
1 shared publication
Latest Publications
- 15 March 2016
- Published by SPIE-Intl Soc Optical Eng
- Vol. 9708, 970853
To assess the reparative ability of differentiated mesenchymal stem cells in a rat critical size bone repair defect model using high frequency co-registered photoacoustic/ultrasound imaging and micro computed tomography
Stem cell based treatments hold great potential and promise to address many unmet clinical needs. The importance of non-invasive imaging techniques to monitor transplanted stem cells qualitatively and quantitatively is crucial. The objective of this study was to create a critical size bone defect in the rat femur and then assess the ability of the differentiated mesenchymal stem cells (MSCs) to repair the defect using high frequency co-registered photoacoustic(PA)/ultrasound(US) imaging and micro computed tomography (μCT) over an 8 week period. Combined PA and US imaging was performed using 256 elements, 21 MHz frequency linear-array transducer combined with multichannel collecting system. In vivo 3D PA and US images of the defect bone in the rat femur were acquired after 4 and 8 weeks of the surgery. 3D co-registered structural such as microvasculature and the functional images such as total concentration of haemoglobin (HbT) and the haemoglobin oxygen saturation (sO2) were obtained using PA and US imaging. Bone formation was assessed after 4 and 8 weeks of the surgery by μCT. High frequency linear-array based coregistered PA/US imaging has been found promising in terms of non-invasiveness, sensitivity, adaptability, high spatial and temporal resolution at sufficient depths for the assessment of the reparative ability of MSCs in a rat critical size bone repair defect model. © (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
- 15 March 2016
- Published by SPIE-Intl Soc Optical Eng
- Vol. 9708, 970853
To assess the reparative ability of differentiated mesenchymal stem cells in a rat critical size bone repair defect model using high frequency co-registered photoacoustic/ultrasound imaging and micro computed tomography
Stem cell based treatments hold great potential and promise to address many unmet clinical needs. The importance of non-invasive imaging techniques to monitor transplanted stem cells qualitatively and quantitatively is crucial. The objective of this study was to create a critical size bone defect in the rat femur and then assess the ability of the differentiated mesenchymal stem cells (MSCs) to repair the defect using high frequency co-registered photoacoustic(PA)/ultrasound(US) imaging and micro computed tomography (μCT) over an 8 week period. Combined PA and US imaging was performed using 256 elements, 21 MHz frequency linear-array transducer combined with multichannel collecting system. In vivo 3D PA and US images of the defect bone in the rat femur were acquired after 4 and 8 weeks of the surgery. 3D co-registered structural such as microvasculature and the functional images such as total concentration of haemoglobin (HbT) and the haemoglobin oxygen saturation (sO2) were obtained using PA and US imaging. Bone formation was assessed after 4 and 8 weeks of the surgery by μCT. High frequency linear-array based coregistered PA/US imaging has been found promising in terms of non-invasiveness, sensitivity, adaptability, high spatial and temporal resolution at sufficient depths for the assessment of the reparative ability of MSCs in a rat critical size bone repair defect model. © (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
- Open Access
- 31 December 2006
- Published by Elsevier in Molecular Therapy
- Vol. 13, S137-S138
361. Lentiviral Vector Transduction Efficiency and Biosafety Profile of Adult Mesenchymal Stem Cells
- 31 December 2006
- Published by Elsevier in Molecular Therapy
- Vol. 13, S137-S138
Open Access361. Lentiviral Vector Transduction Efficiency and Biosafety Profile of Adult Mesenchymal Stem Cells
- Top Cited PapersOpen Access
- 8 December 2003
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (12) , 3464-3474
Stem cell therapy in a caprine model of osteoarthritis
Objective: To explore the role that implanted mesenchymal stem cells may play in tissue repair or regeneration of the injured joint, by delivery of an autologous preparation of stem cells to caprine knee joints following induction of osteoarthritis (OA).Methods: Adult stem cells were isolated from caprine bone marrow, expanded in culture, and transduced to express green fluorescent protein. OA was induced unilaterally in the knee joint of donor animals by complete excision of the medial meniscus and resection of the anterior cruciate ligament. After 6 weeks, a single dose of 10 million autologous cells suspended in a dilute solution of sodium hyaluronan was delivered to the injured knee by direct intraarticular injection. Control animals received sodium hyaluronan alone.Results: In cell‐treated joints, there was evidence of marked regeneration of the medial meniscus, and implanted cells were detected in the newly formed tissue. Degeneration of the articular cartilage, osteophytic remodeling, and subchondral sclerosis were reduced in cell‐treated joints compared with joints treated with vehicle alone without cells. There was no evidence of repair of the ligament in any of the joints.Conclusion: Local delivery of adult mesenchymal stem cells to injured joints stimulates regeneration of meniscal tissue and retards the progressive destruction normally seen in this model of OA.
- 8 December 2003
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (12) , 3464-3474
Top Cited PapersOpen AccessStem cell therapy in a caprine model of osteoarthritis
Objective: To explore the role that implanted mesenchymal stem cells may play in tissue repair or regeneration of the injured joint, by delivery of an autologous preparation of stem cells to caprine knee joints following induction of osteoarthritis (OA).Methods: Adult stem cells were isolated from caprine bone marrow, expanded in culture, and transduced to express green fluorescent protein. OA was induced unilaterally in the knee joint of donor animals by complete excision of the medial meniscus and resection of the anterior cruciate ligament. After 6 weeks, a single dose of 10 million autologous cells suspended in a dilute solution of sodium hyaluronan was delivered to the injured knee by direct intraarticular injection. Control animals received sodium hyaluronan alone.Results: In cell‐treated joints, there was evidence of marked regeneration of the medial meniscus, and implanted cells were detected in the newly formed tissue. Degeneration of the articular cartilage, osteophytic remodeling, and subchondral sclerosis were reduced in cell‐treated joints compared with joints treated with vehicle alone without cells. There was no evidence of repair of the ligament in any of the joints.Conclusion: Local delivery of adult mesenchymal stem cells to injured joints stimulates regeneration of meniscal tissue and retards the progressive destruction normally seen in this model of OA.
- 25 August 2003
- Published by Wiley in Birth Defects Research Part C: Embryo Today: Reviews
- Vol. 69 (3) , 250-256
Biology and clinical applications of mesenchymal stem cells
Stem cell populations are found in most adult tissues and, in general, their differentiation potential may reflect the local cell population. Hematopoietic, epidermal, mesenchymal, neural and hepatic stem cells have been described. It may be that, in the adult, these cells are the reservoirs of reparative cells that are mobilized following injury and migrate to the wound site where, in cooperation with local cells, they participate in the repair response. Mesenchymal stem cells, isolated from the bone marrow, have the capacity to differentiate into cells of connective tissues. Some striking examples of the therapeutic use of MSCs have been reported recently in applications such as coronary artery disease, spinal cord injury, Parkinson's Disease, and liver regeneration. In orthopaedic medicine, MSC therapy has been applied in bone and cartilage repair and in the treatment of osteoarthritis. The question of the host response to implanted MSCs is critical as these cells are being evaluated in clinical applications. There are several aspects to the implanted cell‐host interaction that need to be addressed as we attempt to understand the mechanisms underlying stem cell therapies. These are (1) the host immune response to implanted cells, (2) the homing mechanisms that guide delivered cells to a site of injury, and (3) differentiation of implanted cells under the influence of local signals. Birth Defects Research (Part C) 69;250–256, 2003.
- 25 August 2003
- Published by Wiley in Birth Defects Research Part C: Embryo Today: Reviews
- Vol. 69 (3) , 250-256
Biology and clinical applications of mesenchymal stem cells
Stem cell populations are found in most adult tissues and, in general, their differentiation potential may reflect the local cell population. Hematopoietic, epidermal, mesenchymal, neural and hepatic stem cells have been described. It may be that, in the adult, these cells are the reservoirs of reparative cells that are mobilized following injury and migrate to the wound site where, in cooperation with local cells, they participate in the repair response. Mesenchymal stem cells, isolated from the bone marrow, have the capacity to differentiate into cells of connective tissues. Some striking examples of the therapeutic use of MSCs have been reported recently in applications such as coronary artery disease, spinal cord injury, Parkinson's Disease, and liver regeneration. In orthopaedic medicine, MSC therapy has been applied in bone and cartilage repair and in the treatment of osteoarthritis. The question of the host response to implanted MSCs is critical as these cells are being evaluated in clinical applications. There are several aspects to the implanted cell‐host interaction that need to be addressed as we attempt to understand the mechanisms underlying stem cell therapies. These are (1) the host immune response to implanted cells, (2) the homing mechanisms that guide delivered cells to a site of injury, and (3) differentiation of implanted cells under the influence of local signals. Birth Defects Research (Part C) 69;250–256, 2003.
- Top Cited PapersOpen Access
- 7 March 2002
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (3) , 704-713
Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis
Objective: Mesenchymal stem cells (MSCs) are resident in the bone marrow throughout normal adult life and have the capacity to differentiate along a number of connective tissue pathways, among them bone, cartilage, and fat. To determine whether functionally normal MSC populations may be isolated from patients with advanced osteoarthritis (OA), we have compared cells from patients undergoing joint replacement with cells from normal donors. Cell populations were compared in terms of yield, proliferation, and capacity to differentiate.Methods: MSCs were prepared from bone marrow aspirates obtained from the iliac crest or from the tibia/femur during joint surgery. In vitro chondrogenic activity was measured as glycosaminoglycan and type II collagen deposition in pellet cultures. Adipogenic activity was measured as the accumulation of Nile Red O‐positive lipid vacuoles, and osteogenic activity was measured as calcium deposition and by von Kossa staining.Results: Patient‐derived MSCs formed colonies in primary culture that were characteristically spindle‐shaped with normal morphology. The primary cell yield in 36 of 38 cell cultures from OA donors fell within the range found in cultures from normal donors. However, the proliferative capacity of patient‐derived MSCs was significantly reduced. There was a significant reduction in in vitro chondrogenic and adipogenic activity in cultures of patient‐derived cells compared with that in normal cultures. There was no significant difference in in vitro osteogenic activity. There was no decline in chondrogenic potential with age in cells obtained from individuals with no evidence of OA.Conclusion: These results raise the possibility that the increase in bone density and loss of cartilage that are characteristic of OA may result from changes in the differentiation profile of the progenitor cells that contribute to the homeostatic maintenance of these tissues.
- 7 March 2002
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (3) , 704-713
Top Cited PapersOpen AccessReduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis
Objective: Mesenchymal stem cells (MSCs) are resident in the bone marrow throughout normal adult life and have the capacity to differentiate along a number of connective tissue pathways, among them bone, cartilage, and fat. To determine whether functionally normal MSC populations may be isolated from patients with advanced osteoarthritis (OA), we have compared cells from patients undergoing joint replacement with cells from normal donors. Cell populations were compared in terms of yield, proliferation, and capacity to differentiate.Methods: MSCs were prepared from bone marrow aspirates obtained from the iliac crest or from the tibia/femur during joint surgery. In vitro chondrogenic activity was measured as glycosaminoglycan and type II collagen deposition in pellet cultures. Adipogenic activity was measured as the accumulation of Nile Red O‐positive lipid vacuoles, and osteogenic activity was measured as calcium deposition and by von Kossa staining.Results: Patient‐derived MSCs formed colonies in primary culture that were characteristically spindle‐shaped with normal morphology. The primary cell yield in 36 of 38 cell cultures from OA donors fell within the range found in cultures from normal donors. However, the proliferative capacity of patient‐derived MSCs was significantly reduced. There was a significant reduction in in vitro chondrogenic and adipogenic activity in cultures of patient‐derived cells compared with that in normal cultures. There was no significant difference in in vitro osteogenic activity. There was no decline in chondrogenic potential with age in cells obtained from individuals with no evidence of OA.Conclusion: These results raise the possibility that the increase in bone density and loss of cartilage that are characteristic of OA may result from changes in the differentiation profile of the progenitor cells that contribute to the homeostatic maintenance of these tissues.
- 1 January 2002
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 38 (8) , 457-466
CHONDROGENIC DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS WITHIN AN ALGINATE LAYER CULTURE SYSTEM
Human mesenchymal stem cells (hMSCs) derived from bone marrow have the capacity to differentiate along a number of connective tissue pathways and are an attractive source of chondrocyte precursor...
- 1 January 2002
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 38 (8) , 457-466
CHONDROGENIC DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS WITHIN AN ALGINATE LAYER CULTURE SYSTEM
Human mesenchymal stem cells (hMSCs) derived from bone marrow have the capacity to differentiate along a number of connective tissue pathways and are an attractive source of chondrocyte precursor...
- 1 November 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (2) , 519-524
The SH-3 and SH-4 Antibodies Recognize Distinct Epitopes on CD73 from Human Mesenchymal Stem Cells
- 1 November 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (2) , 519-524
The SH-3 and SH-4 Antibodies Recognize Distinct Epitopes on CD73 from Human Mesenchymal Stem Cells
- Top Cited Papers
- 1 August 2001
- Published by Elsevier in Experimental Cell Research
- Vol. 268 (2) , 189-200
Chondrogenic Differentiation of Mesenchymal Stem Cells from Bone Marrow: Differentiation-Dependent Gene Expression of Matrix Components
- 1 August 2001
- Published by Elsevier in Experimental Cell Research
- Vol. 268 (2) , 189-200
Top Cited PapersChondrogenic Differentiation of Mesenchymal Stem Cells from Bone Marrow: Differentiation-Dependent Gene Expression of Matrix Components